• Neovasc (Vancouver, British Columbia) reported appointments to new marketing and sales positions. Cynthia Roney was named VP of marketing and Sean Moore VP of sales. Roney was president/CEO of Xillix Technologies, which was acquired by Novadaq Technologies, while Moore was director of sales at Medical Ventures. Neovasc is comprised of the former Medical Ventures, Neovasc Medical Ltd. and B-Balloon Ltd.

• René Spaargaren, MD, has been named chief medical officer of Stentys (Paris). Previously, he was VP of international clinical affairs at ev3. Stentys is making a drug-eluting stent for treatment of blocked coronary artery bifurcations so that patients might avoid open-chest surgery.

• Tryton Medical (Research Triangle Park, North Carolina) has named Brett Farabaugh CFO and Douglas Ferguson VP of regulatory & clinical. Farabaugh was CFO for StrikeIron, while Ferguson has more than 18 years of experience in regulatory and clinical affairs. Tryton Medical makes stent systems.